The drug industry is a barrier to diabetes care in poor countries

In many parts of the world, people with type 1 diabetes (whether or not the condition is diagnosed) still die for want of insulin, and those with type 2 diabetes go without treatments that prolong life at minimal cost: metformin, antihypertensives, and statins (BMJ)